Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Open-label Study to Investigate PF-08046876 in Adult Participants With Advanced Solid Tumors.

NCT07090499 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07090499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Open-label Study to Investigate PF-08046876 in Adult Participants With Advanced Solid Tumors.
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Recruiting
Start date
August 20, 2025
Completion date
July 8, 2029
Enrollment
540 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-small cell lung cancer, advanced/metastatic solid tumors, bladder cancer, carcinoma, non small cell lung, carcinoma, squamous cell of head and neck, esophageal adenocarcinoma, esophageal cancer, esophageal squamous cell carcinoma, gastroesophageal junction adenocarcinoma, head and neck cancer, pancreatic adenocarcinoma, pancreatic cancer, urothelial carcinoma